<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis B also was examined in a study of data from 10 European countries. Residual sera were combined with sera from samples available at national serum banks [
 <xref ref-type="bibr" rid="CR65">65</xref>]. Testing assays and algorithms were standardized to allow cross-country comparisons. The authors also collected information on country-specific vaccination policies. Six of the ten countries reported low levels (&lt;3 %) of antibodies to hepatitis B core antigen. Of the eight countries testing for HBV surface antigen (HBsAg), Romania had the highest prevalence (5.6 %); the remaining seven countries had prevalence &lt;1 %. Countries can apply findings from such comparisons to modify and adjust their own vaccination policies.
</p>
